Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2019 - 2025)

Xtant Medical Holdings has reported Asset Writedowns and Impairment over the past 9 years, most recently at $78000.0 for Q3 2025.

  • Quarterly Asset Writedowns and Impairment rose 234.48% to $78000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $723000.0 through Sep 2025, up 150.17% year-over-year, with the annual reading at $485000.0 for FY2024, 35.85% up from the prior year.
  • Asset Writedowns and Impairment was $78000.0 for Q3 2025 at Xtant Medical Holdings, up from -$51000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $1.4 million in Q3 2022 and troughed at -$58000.0 in Q3 2024.
  • The 5-year median for Asset Writedowns and Impairment is $129000.0 (2024), against an average of $233947.4.
  • Year-over-year, Asset Writedowns and Impairment skyrocketed 7754.55% in 2021 and then crashed 139.53% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $864000.0 in 2021, then crashed by 71.76% to $244000.0 in 2022, then tumbled by 116.8% to -$41000.0 in 2023, then surged by 478.05% to $155000.0 in 2024, then tumbled by 49.68% to $78000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Asset Writedowns and Impairment are $78000.0 (Q3 2025), -$51000.0 (Q2 2025), and $541000.0 (Q1 2025).